Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

15.2K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The dual role of the microbiome in sepsis: A complex interplay between pathogenicity and protection.

Physics of life reviews·2026
Same author

Unraveling the enigma: Post-translational modifications in psychiatric disorders and their regulatory mechanisms.

Journal of translational internal medicine·2026
Same author

Systemic inflammatory indicators and their clinical correlations in prurigo nodularis: A multicenter cross-sectional study in China.

JAAD international·2026
Same author

Interplay between ischemia-reperfusion and metabolic reprogramming.

Apoptosis : an international journal on programmed cell death·2026
Same author

Pan-chloroplast genome of Coptis species reveals genetic divergence and medicinal materials identification.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Cell death crosstalk in NET-Driven inflammation: mechanisms, disease contexts, and therapeutic perspectives.

Biomarker research·2026

Related Experiment Video

Updated: Dec 8, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.8K

Interleukin-17 and ischaemic stroke.

Qiaohui Zhang1, Yan Liao1, Zhenquan Liu2

  • 1Chinese Medical Institute, Beijing University of Chinese Medicine, Beijing, China.

Immunology
|September 16, 2020
PubMed
Summary
This summary is machine-generated.

Interleukin-17 (IL-17) cytokines promote inflammation and worsen outcomes in ischaemic stroke. Understanding IL-17

Keywords:
IL-17Ainflammationinterleukin-17 (IL-17)stroketherapy

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

332
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

12.2K

Related Experiment Videos

Last Updated: Dec 8, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.8K
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

332
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

12.2K

Area of Science:

  • Immunology
  • Neurology
  • Pathophysiology

Background:

  • Interleukin-17 (IL-17) is a cytokine family with pro-inflammatory roles.
  • IL-17 signaling is implicated in autoimmune diseases like rheumatoid arthritis and multiple sclerosis.
  • Ischaemic stroke involves complex pathophysiological processes where inflammation contributes to poor prognosis.

Purpose of the Study:

  • To review the pathological modulation of the IL-17 family in ischaemic stroke.
  • To elucidate the mechanisms by which IL-17 contributes to stroke pathology.
  • To explore potential therapeutic insights targeting IL-17 in stroke.

Main Methods:

  • Literature review focusing on IL-17 family members and their receptors (IL-17Rs).
  • Analysis of inflammatory factors and immune cell involvement in post-stroke injury.
  • Synthesis of current understanding of IL-17's role in cerebral ischaemia.

Main Results:

  • IL-17 family members are involved in promoting inflammatory responses post-ischaemic stroke.
  • IL-17 signaling contributes to secondary injury following cerebral ischaemia.
  • The precise functions of IL-17 in stroke pathogenesis require further elucidation.

Conclusions:

  • IL-17 plays a significant role in the inflammatory processes and secondary damage associated with ischaemic stroke.
  • Further research into IL-17 mechanisms is crucial for developing novel stroke therapies.
  • Targeting IL-17 pathways may offer new therapeutic strategies for improving stroke outcomes.